Fintel reports that on May 4, 2023, HC Wainwright & Co. initiated coverage of Absci (NASDAQ:ABSI) with a Buy recommendation.
Analyst Price Forecast Suggests 601.76% Upside
As of April 24, 2023, the average one-year price target for Absci is 8.77. The forecasts range from a low of 3.03 to a high of $14.70. The average price target represents an increase of 601.76% from its latest reported closing price of 1.25.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Absci is 18MM, an increase of 213.40%. The projected annual non-GAAP EPS is -1.08.
What is the Fund Sentiment?
There are 179 funds or institutions reporting positions in Absci. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to ABSI is 0.02%, a decrease of 8.45%. Total shares owned by institutions decreased in the last three months by 5.29% to 42,494K shares. 
The put/call ratio of ABSI is 0.23, indicating a bullish outlook.
What are Other Shareholders Doing?
Redmile Group holds 8,031K shares representing 8.68% ownership of the company. No change in the last quarter.
Casdin Capital holds 7,363K shares representing 7.96% ownership of the company. In it's prior filing, the firm reported owning 7,719K shares, representing a decrease of 4.83%. The firm decreased its portfolio allocation in ABSI by 24.51% over the last quarter.
FDGRX - Fidelity Growth Company Fund holds 4,061K shares representing 4.39% ownership of the company. In it's prior filing, the firm reported owning 4,139K shares, representing a decrease of 1.92%. The firm decreased its portfolio allocation in ABSI by 14.57% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 1,453K shares representing 1.57% ownership of the company. No change in the last quarter.
FGKFX - Fidelity Growth Company K6 Fund holds 1,306K shares representing 1.41% ownership of the company. In it's prior filing, the firm reported owning 1,335K shares, representing a decrease of 2.19%. The firm decreased its portfolio allocation in ABSI by 16.78% over the last quarter.
See all Absci regulatory filings.This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
